{"organizations": [], "uuid": "7d8439ed465908e3e3f903b6f2669d8395fcb619", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/5", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/13/globe-newswire-ait-therapeutics-announces-year-end-2017-financial-results-conference-call-and-webcast.html", "country": "US", "domain_rank": 767, "title": "AIT Therapeutics Announces Year End 2017 Financial Results Conference Call and Webcast", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-13T15:00:00.000+02:00", "replies_count": 0, "uuid": "7d8439ed465908e3e3f903b6f2669d8395fcb619"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/13/globe-newswire-ait-therapeutics-announces-year-end-2017-financial-results-conference-call-and-webcast.html", "ord_in_thread": 0, "title": "AIT Therapeutics Announces Year End 2017 Financial Results Conference Call and Webcast", "locations": [], "entities": {"persons": [], "locations": [{"name": "new york", "sentiment": "none"}], "organizations": [{"name": "eastern time", "sentiment": "negative"}, {"name": "ait therapeutics inc.", "sentiment": "none"}, {"name": "wswire", "sentiment": "none"}, {"name": "ait therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Call Scheduled for Monday, March 19, 2018 at 4:30pm Eastern Time.\nNEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung infections and pulmonary hypertension, will report financial results for the year ended December 31, 2017 and host a conference call and webcast at 4:30pm Eastern Time on Monday, March 19, 2018.\nConference Call & Webcast Monday, March 19 th @ 4:30pm Eastern Time\nDomestic: 800-289-0438 International: 323-994-2083 Passcode: 1979356 Webcast: http://public.viavid.com/index.php?id=128779 Replays available through April 2: Domestic: 844-512-2921 International: 412-317-6671 Conference ID: 1979356\nAbout AIT Therapeutics Inc.\nAIT Therapeutics Inc. is a clinical-stage biopharmaceutical company using nitric oxide (NO) to treat serious lung infections and pulmonary hypertension. The Company is currently applying its therapeutic expertise to treat lower respiratory tract infections that are not effectively addressed with current standards of care. AIT Therapeutics is advancing its revolutionary NO respiratory targeted system in clinical trials for the treatment of bronchiolitis and nontuberculous mycobacteria (NTM). For more information, visit www.AIT-Pharm.com .\nCONTACT\nSteven Lisi\nChief Executive Officer\nAIT Therapeutics, Inc.\nSteve@AIT-Pharm.com\nBob Yedid\nLifeSci Advisors, LLC\nBob@LifeSciAdvisors.com\n(646) 597 6989\nSource:AIT Therapeutics, Inc.", "external_links": ["https://www.globenewswire.com/Tracker?data=0O3_cyUXTGXai83eK9A7zeaCXb8AeP9xq91qNQcHh9iKKnOG5PG3PJNMyFkZxEwVCDUfbWnFTgXy81P_4AZXpMcK2Y-SxH-RCDKlJiOgbFo=", "https://www.globenewswire.com/Tracker?data=gM75-Z7dsUKCLVVmMDcv6r8WRnGKU7LVujaNsY0zLKFE_o-plR8Lsdtp_d9OIVm9rI_E8xeUr6E5fS6OXuGxDw==", "https://www.globenewswire.com/Tracker?data=P3q00OLLt5l4J4f8-WTZ_W0JWlN_xs4CuEyuE_5_9A9BmGCvZE068XFDCxJ9KC8u6IrXhtTb2MXGIVWNEe2Lum8O-rMXLn4AALU8qBJG0Yk=", "https://www.globenewswire.com/NewsRoom/AttachmentNg/f6447845-948b-43a6-860f-1f7f0f858c60", "http://public.viavid.com/index.php?id=128779"], "published": "2018-03-13T15:00:00.000+02:00", "crawled": "2018-03-13T18:14:13.013+02:00", "highlightTitle": ""}